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Abstract 
Two continuous processes, the spray drying method, producing microparticles in presence of hot 
gas flow, and the electrospinning technology, producing continuous polymer nanofibers at low 
temperature under high electric fields, were investigated and compared the first time. Both 
techniques were used to prepare slow release caffeine (as a model of rapidly water-soluble drug) 
using water-insoluble, biocompatible and bioresorbable PLGA and PLA as polymeric matrix. 
The structural characterization of the obtained samples was performed using SEM, XRD, DSC 
and at-line Raman mapping, while in vitro dissolution was detected by UV spectrophotometer. 
We found that the release profile of a highly water soluble drug can be adjusted to the 
requirements through the investigated continuous technologies. Solid molecular dispersion of 
caffeine at colloidal level could be prepared in PLA matrix using electrostatic spinning. 
Furthermore the continuous nonwoven structure of ultrafine fibers, produced this way, allows 
easer handling than that of independent fine particle’s. On the other hand continuous production 
of drug loaded microspheres with slightly less performance can be performed with the 
conventional technology of spray drying which is well known in the pharmaceutical industry. 
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1. Introduction 
The control of drug release poses great challenges for the pharmaceutical industry regardless 
of poor or high solubility of the active pharmaceutical ingredient (API) in water. In the case of 
highly water-soluble active drugs, which are otherwise rapidly eliminated from the body, the 
requirement is to find the appropriate technology and excipients to achieve smooth and sustained 
drug release. The methods assigned for this purpose should be gentle and productive enough 
allowing efficient manufacturing on industrial scale. Although both the well-known spray drying 
(SD) and the recently introduced electrospinning (ES) techniques have been already used for 
forming controlled release formulations [1-5], these were, surprisingly, not yet tested with the 
same formulation comparing their capability. 
Several investigations have revealed the suitability of SD for producing bioresorbable drug 
delivery systems in a continuous manner [6-8], providing the amorphous form of the APIs (in 
most cases). More recently, similar reports have appeared regarding ES [9-11]. The high 
tendency for amorphization in the cases of ES and SD is ascribed to the fast evaporation of the 
solvent [12], which results in amorphous solid dispersion or solution of the drug in the polymer 
matrix [9]. Amorphous state of a drug promotes its dissolution advantageously comparing to the 
crystalline state if it is stabilized by the surrounding polymer phase.  is a disadvantage, however, 
that the SD technique requires elevated temperature that can damage thermally unstable 
compounds [13]. 
In order to achieve controlled release of drugs of high water solubility with these techniques, 
the selected polymer matrices must not be (or just very slowly) soluble in water allowing smooth 
release of drug. Poly(lactic acid) (PLA) and poly(lactide-co-glycolide) (PLGA) are such 
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bioresorbable and thermoplastic water-insoluble polymers (approved by all the relevant 
authorities for use in human subjects). These biocompatible polymers have been employed as 
suture materials [8], inter-body cages [14], scaffolds for tissue engineering [15], and 
biodegradable drug delivery systems [16] with sustained drug release [17]. Both PLA and PLGA 
matrices are frequently applied to achieve sustained drug release , but a so-called “burst effect” is 
experienced in many cases [18, 19]. Significant initial burst release can result in such a high drug 
concentration in the blood that means significant risk to the patient’s health. Furthermore, early 
depletion of the drug in these cases is a further disadvantage regarding the intended long-term 
release. Currently, burst release values between 10% and 80%, depending on the encapsulated 
drug load, are commonly seen in publications as well as in marketed products [20].  
The objective of this study was to prepare sustained-release caffeine (as a model of water-
soluble API) by spray drying and electrospinning and evaluate the capabilities of these methods 
for amorphization and controlled release by solid-phase analytical methods and in vitro 
dissolution tests.  
2. Experimental 
2.1 Materials 
The poly(lactide-co-glycolide) (PLGA) block copolymer used in this work was PURASORB® 
PDLG 5004, Mw = 40,000, inherent viscosity of 0.4 dl/g (25 °C), it contains 50 % D,L-lactide. 
Polylactic acid homopolymer was PURASORB® PL 24 (PLA, D isomer < 5 %) (both obtained 
from PURAC; Netherlands). Caffeine was purchased from Sigma-Aldrich Chemie GmbH 
(Germany). Dichloromethane (CH2Cl2); chloroform (CHCl3) and N, N-dimethylformamide 
(DMF) was obtained from Reanal Private Ltd. (Hungary). 
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Figure 1  
2.2 Spray drying and electrospinning processes 
Microspheres with and without caffeine were prepared using spray drying method. For this 
purpose, PLGA of 5 % (w/v) and PLA of 1 % (w/v) concentrations, respectively, were dissolved 
in CH2Cl2 and caffeine was added in different concentrations (0-100 w/w%) to the solution of the 
polymers. The code and concentration of samples prepared are given in Table 1. Spray-drying 
was performed with a Pro-Cep-T 4M8-TriX spray dryer (ProCept, Belgium) using a 0.4 mm two-
fluid nozzle. The process parameters were as follows: atomization air pressure 1 bar; inlet air 
temperature 40 °C; outlet air temperature 38 °C; pump control 2.24 mL/min; airflow 0.8 m3 min-
1
.  
Table 1 
Electrospun fibers were prepared using and 4, 6 and 10 (w/w %) PLA solution in CHCl3: 
DMF = 6:1 co-solvent system to which 0, 10, 20 or 50 (w/w) % caffeine was added. All 
electrospinning experiments were performed at room temperature (24 ± 2 °C) assembling the 
fibers on aluminum foil affixed to the collector. To perform electrospinning, an infusion pump 
(Aitecs SEP-10S Plus syringe pump, Lithuania) and constant voltage ranging from 20–30 kV 
were applied provided by a direct current power supplier (NT-35 High Voltage DC Supply 
MA2000, Hungary). The distance between the collector and the spinneret (with 0.4 mm internal 
diameter) was 23 cm and the solutions were fed with 0.13 mL/min rate. 
The yields were determined based on outcome of the solid product related to the solid starting 
materials. 
2.3 At-line Raman spectrometry and mapping 
At line measurements were performed using a LabRAM 300 micro-Raman spectrometer 
manufactured by Jobin Yvon Horiba (France) and equipped with a fiber optic coupled probe, 
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using a 400 mW, 785 nm laser source and an air cooled CCD detector. The instrument is 
described elsewhere [21]. All spectra were detected over the range of 500–1800 cm–1 
approximately 4 cm-1 resolution provided by a grating monochromator of 950 groove/mm. In 
each experiment the acquisition time was 0.5 s and 80 spectra were averaged. Each sample was 
measured at 25 different point of the surface (spectra from different locations were not averaged). 
Chemical mapping was carried out on selected electrospun and spray-dried samples using 
above mentioned micro-Raman spectrometer to obtain information on their API distribution. In 
these cases, an external laser source of 532 nm frequency-doubled Nd-YAG was used. The 
spectra were recorded on the spectral range of 400-1835 cm-1. The high resolution maps were 
collected with an objective of ×100 magnification (laser spot size: ∼0.7 μm) and 1 μm step size. 
The acquired image consisted of 41 × 41 points (pixels). Each single spectrum was acquired for 
5-7 s and 5 or 8 spectra were averaged in each pixel depending on the available measurement 
time.  
 
2.4 Data analysis of Raman spectra  
Before chemometric evaluation, piece-wise linear base-line correction was applied on all 
spectra (using the same baseline points for all the maps and reference spectra). Afterwards, 
spectra were normalized to unit area. Concentrations of the ingredients in the samples were 
computed using Partial Least Squares (PLS) regression. A PLS model was built on a calibration 
set consisting of multiple spray-dried samples with various concentration levels (Table 1). The 
details of PLS can be found in the literature [22]. The number of latent variables was set to 2 as 
the samples consisted of 2 components (and all subsequent latent variables (loadings) contained 
mostly noise and instrumental disturbance factors that did not hold valuable chemical 
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information). Best results were obtained when mean centering was also applied on the calibration 
and prediction sets as a third preprocessing step. 
The efficiency of the calibration and validation model was calculated using the root mean 
square error of calibration (RMSEC), cross-validation (RMSECV), and prediction (RMSEP). 
Besides, the corresponding coefficients of determination (R2) were calculated as well. For 
RMSECV, a contiguous block cross-validation was performed: in each step, a contiguous block 
of spectra of the calibration set was deleted from the calibration set and a model was built with 
the remaining spectra. The errors were calculated based on the samples left out and the procedure 
was repeated with leaving out the next block of spectra in the calibration matrix. In practice, this 
approach means leaving out all spectra for a particular concentration at a time. 
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Equation 1 Root mean square error calculation 
All calculations were performed in MATLAB 7.6.0 (Mathworks, USA) with PLS_Toolbox 
6.0.1 and MIA_Toolbox 2.0.1 (Eigenvector Research, USA). 
 
2.5 Scanning electron microscopy (SEM) and polarized microscopy (PM) 
The surface morphology of the microparticles and submicron-sized fibers were investigated 
by a JEOL JSM 6380LA (Tokyo, Japan) scanning electron microscope (acceleration voltage: 10–
30 kV) and an Amplival Carl Zeiss (Jena, Germany) polarized microscope (PM). The images 
were collected with OLYMPUS C4040 Z type camera, the evaluation was performed with the aid 
of DP-Soft software. Samples for SEM were dried under vacuum, mounted on metal stubs, and 
sputter-coated with gold/silver binary alloy. 
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2.6 X-ray diffractometry (XRD) 
The pure caffeine, PLGA, PLA and caffeine-loaded biodegradable microspheres and fibers 
were analyzed with a PANalytical X’pert Pro X-ray MPD diffractometer (Almelo, The 
Netherlands). The measurements were under CuKα (λ=1.5406 Å), 40 kV and 30 mA as X-ray 
source with Kb (Ni) filter. The diffraction patterns were collected with 2θ ranging from 2 or 4 ° 
to 42°.  
 
2.7 Differential scanning calorimetry (DSC) 
Thermal analyses of all the above-mentioned samples were carried out using SETARAM 
DSC 92 (Calure, France). 10 – 20 mg sample was in an aluminum pan. An empty aluminium pan 
was used as reference. The measurements were carried out in 1.6 bar nitrogen atmosphere. The 
heating rate was 10 °Cmin-1. The heating scans were performed from 30 to 300 °C. 
 
2.8 In vitro release studies of caffeine 
In vitro drug dissolution tests were performed in 900 mL at 37±1 °C tempered distilled water 
by Erweka DT6 dissolution tester (Erweka, Heusenstamm, Germany) with 50 min-1 stirring 
speed. Solid dispersions, contained about 10 mg API, were filled in spherical shape wire mesh 
and it was dipped in the dissolution bath in order to ensure the total surface wettability of the 
microparticles and fibers. 5 mL sample was taken at various intervals and its caffeine 
concentration was determined by UV spectrophotometry at 274 nm (Hewlett-Packard - HP 
8452A Diode Array UV/VIS spectrophotometer). 
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3. Results and discussion 
Spray drying and electrospinning technologies enable continuous production of the 
biodegradable drug delivery systems. Raman spectrometry, as non-destructive analytical method, 
is suitable for monitoring the structure and the API concentration assisting thus in optimizing the 
process parameters. In order to suppress the rapid release of drug from the matrices, numerous 
formulations were prepared in case of SD by varying also the polymer matrices (PLGA and 
PLA). Considering the results of screening performed by spray drying the electrospinning 
experiments were performed only with the most promising systems.  
3.1 Preparation of spray dried and electrospun systems of various drug concentrations controlled 
by at line Raman spectrometry 
The composition of the prepared samples and the yield of their production are given in Table 
1. The code expresses the way of processing (spray drying: SD, electrospinning: ES), the polymer 
(polylactic acid: PLA, poly(lactide-co-glycolide): PLGA) and the composition as given in the 
table. The yields in the case of electrospinning were significantly better (94 - 97%) than in the 
case of spray drying (generally 50 - 80%) which can be explained by the high efficiency of the 
electrostatic particle collection. Furthermore, the continuous non-woven structure of the 
nanofibers allows much easier handling of the produced material (as a textile) than in the case of 
independent spray dried particles (fine powder).  
Wide scope of the SD compositions, prepared by spray drying, served for evaluating the 
capability of the polymer matrices to control the release of caffeine. As the in vitro release results 
of PLGA, given in section 3.5, were not promising the electrospinning experiments were 
performed with PLA in the concentration range that is realistic for application. Nevertheless, all 
the prepared samples were subjected to structural analysis.  
  
 10
Raman spectrometry, as a potential PAT (process analytical technology) tool [23], was used, 
at the site of spray drying to check the caffeine concentration of the formed objects (ES samples 
were not analyzed this way as electrospinning process is not yet present in pharmaceutical 
industry). Figure 2 shows the spectra of the caffeine-PLGA samples. 
Figure 2  
The crystalline form of caffeine in the samples is represented by its sharp peaks. The two 
peaks of highest intensity at 1328 cm-1 (νC-N stretching vibrations [24]) and at 555 cm-1 (δO=C-
N bending vibrations [25]) are characteristic to caffeine, the intensities of which grow along with 
its concentration in the sample. PLGA does not have any sharp peaks; there is only one 
significant peak at 1769 cm-1 (νC=O stretching vibrations) that diminishes as the concentration of 
PLGA decreases in the samples. 
Figure 3  
Raman spectra of PLA-caffeine mixtures in Figure 3 are also dominated by the same two 
bands characteristic of caffeine (1328 and 555 cm-1) as in the previous series. Regarding the PLA 
matrix, the peak at 1769 cm-1 refers to the same functional group as in the case of PLGA, namely, 
the lactate unit. The intense peak at 872 cm-1 (νC-COO stretching vibrations [26]) is present only 
in samples containing PLA. In order to control the caffeine concentration in the samples 
effectively, the average Raman spectra of the compositions were evaluated using PLS regression 
method (considering the entire spectra, instead of selecting particular vibrational peaks. 
Preliminary studies showed that univariate calibration was not feasible due its high prediction 
error). The spectral dataset contained 11 different caffeine-PLGA and 6 caffeine-PLA samples 
with different mass fractions. (PLGA and PLA sets were evaluated separately.) These datasets 
were divided into two subsets in 6 : 5 and 4 : 2 ratio, respectively. One subset, called calibration 
set, was used to build the regression model. The other subset, called prediction set, was used to 
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predict the predictive performance of the model. The performance of the model was primarily 
evaluated based on the root mean square errors (RMSE), but the coefficients of determination 
(R2) were also calculated. The model plots are shown in Figure 4, while the numeric indicators of 
the regression performance are presented in Table 2. 
Figure 4  
Table 2  
A small degree of nonlinearity was observed in the correspondence of the predicted versus 
the nominal concentration (Figure 4). This is due to the normalization applied. (However, 
normalization could not be avoided as it was required to remove the overall intensity deviations 
among pixels and doing so lead to much higher prediction errors, even though the 
correspondence between predicted and nominal concentrations stays almost completely linear.) 
As no outliers are seen on Figure 4, the results confirm that the composition of the formed 
samples did not change during processing and the PLS regression provides a robust model for 
controlling the concentration of API. This suggest: concentration of API can be examined in fast 
and precise manner by Raman spectrometry which is very useful in semi-continuous or 
continuous processing technologies. 
3.2 Morphology and size of the microparticles and fibers 
The morphology and average diameters of the particles were evaluated by SEM images. 
Figure 5  
As seen on Figure 5, the diameter of caffeine-loaded PLA microspheres was in the range of 3 
– 10 μm. Shape of the spray dried PLA particles are spherical (Figure 5A), but as the caffeine 
concentration increases, the particles start losing their spherical shape: distorted and formless 
particles are obtained (Figure 5C, E). The solid dispersion loses its regular shape gradually, due 
to the increased caffeine content, forming various objects (including doughnut-like particles) in 
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the case of SD_PLA50 samples. These changes can indicate phase separation of the components 
and crystallization of caffeine in the particles. 
The morphology of the ES fibers is shown in Figure 5B, D and F. The average diameter of 
the pure polymeric and caffeine-loaded fibers was determined using the SEM images. Table 3 
summarizes the average diameters of fibers obtained from different compositions. 
Table 3  
A decrease of the fiber diameter with decreasing polymer concentration, enabling the 
preparation of submicron fibers, can be seen in Table 3. In contrast, inclusion of API into the 
PLA matrix increased the fiber diameter. Differences were observed in the surface appearance of 
the fibers as well: rough surface was characteristic to the sample containing 50% caffeine 
(suggesting phase separation), while the surface of fibers containing pure PLA and those with 
PLA and 10% caffeine were smooth (suggesting no phase separation). In order to determine the 
reason of the difference, polarized microscopic (PM) analyses were performed as well. The 
images taken by a polarized light optical microscope are shown in Figure 6. 
Figure 6  
The different appearance of the PLA fibers with 10% and 50% caffeine loading can be also 
recognized in the PM images. The colorful birefringent spots in the fiber of 50% caffeine content 
refer to crystalline parts grown inside the fibers, while the sample with less caffeine loading 
seems to be free of crystalline content. It was therefore assumed that in the ES_PLA10 sample 
the caffeine can be molecularly dispersed. This assumption was further investigated by other 
analytical methods. 
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3.3 DSC results 
The aim of the thermal analysis was the determination of the morphology of the API. At first, 
pure caffeine and the pure polymers were analyzed. Sharp melting endotherms, characteristic to 
the crystalline materials, were visible in DSC curves of caffeine and PLA. In the case of PLGA 
glass transition was observable around 60 °C (Figure 8A). The phase transformation (from Form 
II to Form I) and melting point of caffeine Form II appears at 145 °C and at 234 - 239 °C (Figure 
7B) respectively in accordance with the literature [27]. The enthalpy of the endothermic peak of 
caffeine melting in PLGA SD samples rapidly decreases with the concentration and below 10% 
drug content crystalline drug parts is negligible (Figure 8 and Figure 9). Similarly, within the SD 
PLA matrix the sign of the endothermic melting transition of caffeine disappears between 10-
20% of drug content (Figure 9). Among the DSC curves (Figure 7) of ES fibers, the one for the 
ES_PLA10 sample (of 10% of caffeine content, curve “F”) also suggests perfectly dispersed 
caffeine in the matrix as its separate melting peak cannot be detected. 
Figure 7  
Figure 8  
Figure 9  
Regarding the polymer phase characteristics, enthalpy change can be seen in the 60 - 80 °C 
regions of the curves in Figures 7 (C, D, E, F, G and H). This region includes the glass transition 
followed by increased segmental motion and “cold” crystallization in the course of the heating-up 
process as a consequence of the fast drying applied in the process: The time available for 
segmental arrangement in the course of SD and ES drying processes is not enough for 
crystallization of PLA therefore it becomes complete only when the temperature is raised above 
the glass transition temperature (Tg). The DSC curve of original PLA (see in Figure 7A) does not 
show such transition. 
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3.4 XRD  
Changes of crystallinity induced by the manufacturing processes also were evaluated by X-
ray diffraction measurements. The results are given in Figure 10 and Figure 11. According to the 
diffractograms spray drying resulted in amorphization only at 5% drug content. This result 
suggests that the DSC analysis alone is not suitable for evaluating the morphology of solid 
dispersions. Comparison of SD and ES techniques in the case of systems prepared with PLA 
matrix made clear that amorphization of drug at 10% caffeine concentration is only successful if 
ES is applied. The difference is probably caused by the different rates of solvent evaporation in 
the two methods. The SD produces particles of smaller specific surface releasing solvent less 
readily than the thin fibers formed by ES technique. The lower drying rate and the higher 
temperature of SD process provide sufficient time and mobility for nucleation of a readily 
crystallizing API (such as caffeine). In contrast, the drying and solidification processes are 
extremely rapid when fibers of large specific surface area is formed by ES method [1], 
furthermore, the diffusion, required for nucleation, is limited in the formed fibers owing to the 
partially oriented polymer chains and the excellent diffusion barrier properties of the fiber-air 
interfaces. Thus, even strongly crystallizing active substances can be kept in amorphous form. 
Figure 10  
Figure 11  
The analytical methods applied proved that caffeine can be preserved in an amorphous state 
using an appropriate preparation method (it was not achieved earlier by other technologies). This 
is feasible if ultra-rapid drying process is performed in the presence of an appropriate polymer 
matrix in large proportion. However, increasing the caffeine concentration to 50% the product 
contains crystals even with very rapid drying. 
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3.5 In vitro release studies 
Dissolution tests were performed in order to determine the release profile of the prepared 
solid dispersions. The observed morphological differences were expected to be reflected in the 
dissolution curves of the samples, providing flexibility in matching the dissolution to the 
requirements. 
Figure 12  
One can observe comparing the release profiles of the samples presented in Figure 12 that 
the PLGA, containing hydrophilic as well as hydrophobic units, delayed dissolution of the 
(highly water soluble) caffeine only slightly. Generally three hours was required to get the total 
amount of drug dissolved with the exception of the SD_PLGA5 sample, in which case 12 hours 
was required to evenly dissolve the 5% caffeine. The dissolution profiles of PLA microspheres 
and fibers are shown in Figure 13 which allows the comparison of the kinetics of their 
dissolution. As expected, the more hydrophobic PLA biopolymer released the caffeine slower 
than PLGA, but the difference is moderate in the case of samples containing 50% mainly 
crystalline drug, in which case the release started with a burst effect, then it slowed down. The 
rapid dissolution occurs through the channels caused by larger crystals, while the slow release is 
diffusion controlled. The burst effect was avoided in the case of samples containing the caffeine 
in amorphous form, which, in agreement with our objectives, provided gradual, slow release. 
Amorphous substances are, in principle, rapidly soluble, however, in the present case the steady 
and prolonged dissolution curves can be explained by the fact that the amorphous drug is well 
dispersed in the polymer matrices. 
Figure 13  
The results make clear that the release kinetics of both solvent-based processes is highly 
dependent on the concentration, morphology and distribution of the drug, the duration of the 
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drying, and the hydrophobicity of the matrix material. In the present case the electrospun product 
released the drug slower from ES_PLA50 sample than from the relevant spray-dried sample. 
(Note the dissolution tests were made in aqueous medium and the polymers are not water 
soluble.) For the two strongly retarded formulations (ES_PLA10 and SD_PLA5 samples) the 
complete dissolution profile is presented in Figure 13B showing that the time needed for 
dissolving the total amount of the caffeine is two weeks for SD_PLA5 and as much as four weeks 
for ES_PLA10. Furthermore, the kinetics of dissolution from ES_PLA10 is close to the most 
preferred zero order one. The fact that the total dissolution of API is slower from ES_PLA10 than 
from SD_PLA5 suggests that caffeine forms more homogeneous distribution in the fibers. These 
assumptions was tried to confirm by Raman mapping. 
 
3.6 Raman mapping 
It was assumed that the differences in the dissolution profiles were caused by differences in 
distribution of API as a consequence of partial phase separation 
Figure 14  
Comparison of the three images suggests clear differences in the local intensity of the active 
substance. It is caused by the different spatial distribution within the polymer matrix. The 
inhomogeneity of API distribution in Figure 14A and 14B is obvious, while in 14C homogeneous 
distribution can be seen. In the case of SD_PLA10 and SD_PLA5 samples, the phase separation 
of API and the subsequent crystallization is not prevented (see in Figure 14), while the reason for 
the preferred gradual sustained release from ES_PLA10 is the perfect, probably molecular, 
distribution of the drug in the polymer matrix without any sign of crystalline organization. 
4. Conclusion  
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Both continuous technologies of spray drying and electrostatic spinning made it possible to 
prepare sustained release bioresorbable drug delivery system containing highly water soluble 
caffeine model drug. Production of microparticles with spray drying, using PLA and PLGA 
matrices loaded with caffeine, could be performed with high yield. The structure of spray dried 
particle contains, however, phase separated drug, which tends to crystallize. SD technique 
requires elevated temperature that is not harmful for caffeine but can damage other thermally 
unstable compounds. In the case of electrostatic spinning the polymer solution is not exposed to 
any heat effect and the formed nonwoven structure is easy to handle fitting well to further steps 
of continuous pharmaceutical production. Using electrostatic spinning it proved to be possible to 
produce very fine dispersion of caffeine (probably solid solution) at room temperature in PLA 
matrix when the API content is not higher than 10%. Since caffeine could be amorphized 
perfectly the burst effect could be avoided and the preferred near to zero order dissolution profile 
could be ensured. Both technologies are useful in drug delivery systems and their selection 
depends on the required release profile and on the availability of the facilities. While SD is well 
developed, the scaling-up of ES in pharmaceutically approved way means some challenges yet. 
The formed microparticles and nanofibers (in milled form for instance) can be used in 
subcutaneous injection with controlled drug release. 
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Figure Captions 
Figure 1 Structures of the used drug and polymers in this study: PLGA (A); caffeine (B); PLA 
(C) 
Figure 2 Raman spectra of spray dried caffeine-PLGA solid colloidal dispersion: SD_CAF (A); 
SD_PLGA80 (B); SD_PLGA60 (C); SD_PLGA50 (D); SD_PLGA40 (E); SD_PLGA30 (F); 
SD_PLGA25 (G); SD_PLGA20 (H); SD_PLGA10 (I); SD_PLGA5 (J); SD_PLGA (K) 
Figure 3 Raman spectra of spray dried and electrospun caffeine-PLA systems: SD_PLA80 (A); 
ES_PLA50 (B); SD_PLA50 (C); SD_PLA20 (D); ES_PLA10 (E); SD_PLA10 (F); SD_PLA5 
(G); SD_PLA (H) 
Figure 4 Comparison of PLS regression models regarding PLGA-caffeine (A) and PLA-caffeine 
(B) systems 
Figure 5 SEM images of caffeine loading spray dried and electrospun PLA: SD_PLA (A); 
ES_PLA (B); SD_PLA10 (C); ES_PLA10 (D); SD_PLA50 (E) and ES_PLA50 (F) 
Figure 6 PM images of electrospun PLA with caffeine loading (magnification 100×): ES_PLA50 
(A); ES_PLA10 (B) 
Figure 7 DSC curves of original PLA (A); original caffeine (B); SD_PLA50 (C); ES_PLA50 
(D); SD_PLA10 (E); ES_PLA10 (F); SD_PLA (G) and ES_PLA (H) 
Figure 8 DSC curves of original PLGA (A); SD_PLGA80 (B); SD_PLGA60 (C); SD_PLGA50 
(D); SD_PLGA40 (E); SD_PLGA30 (F); SD_PLGA10 (G); SD_PLGA5 (H) and SD_PLGA (I) 
Figure 9 Enthalpy of the endothermic peak of caffeine melting in PLGA (●) and PLA SD (▲) 
samples 
Figure 10 X-ray diffractogram of caffeine and caffeine loaded PLGA microparticles: original 
caffeine (A); SD_PLGA60 (B); SD_PLGA50 (C); SD_PLGA40 (D); SD_PLGA30 (E); 
SD_PLGA25 (F); SD_PLGA20 (G); SD_PLGA10 (H); SD_PLGA5 (I); SD_PLGA (J) 
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Figure 11 X-ray diffractogram of spray dried and electrospun samples: SD_PLA80 (A); 
SD_PLA50 (B); SD_PLA20 (C); SD_PLA10 (D); SD_PLA5 (E); ES_PLA50 (F); ES_PLA20 
(G); ES_PLA10 (H); SD_PLA (I) and original PLA (J) 
Figure 12 Release profiles of caffeine loaded PLGA microspheres 
Figure 13 Release profiles of PLA microspheres and fibers loaded with caffeine (A) and total 
dissolution of SD_PLA5 and ES_PLA10 (B) 
Figure 14 Raman maps of the SD_PLA10 (A); SD_PLA5 (B) and ES_PLA10 (C), color code: 
from black (0.00) to yellow (0.50) for the API spectral concentration 
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Tables 
Table 1 The composition of spray dried microparticles and electrospun samples 
Sample code Caffeine (w/w %) 
PLA 
(w/w %) 
PLGA 
(w/w %) 
Yield 
(%) 
SD_PLA80 80 20 - 79 
SD_PLA50 50 50 - 74 
SD_PLA20 20 80 - 54 
SD_PLA10 10 90 - 54 
SD_PLA5 5 95 - 72 
SD_PLA 0 100 - 76 
SD_CAF 100 - - 65 
SD_PLGA80 80 - 20 69 
SD_PLGA60 60 - 40 72 
SD_PLGA50 50 - 50 76 
SD_PLGA40 40  60 62 
SD_PLGA30 30  70 67 
SD_PLGA25 25  75 68 
SD_PLGA20 20  80 63 
SD_PLGA10 10 - 90 48 
SD_PLGA5 5 - 95 35 
SD_PLGA 0 - 100 46 
ES_PLA50 50 50 - 97 
ES_PLA20 20 80 - 95 
ES_PLA10 10 90 - 95 
ES_PLA 0 100 - 94 
 
 
Table 2 Results of regression regarding the PLGA-caffeine and PLA-caffeine systems 
Regression 
method R
2
C R2CV R2pred 
RMSEC RMSECV RMSEP
(m/m%) 
PLGA-caffeine 
PLS 0.978 0.970 0.974 4.83 6.17 6.28 
PLA-caffeine 
PLS 0.957 0.892 0.958 6.61 10.59 4.60 
 
 
Table 3 Diameter of electrospun PLA fibers prepared from solutions with different polymer 
concentrations 
Table 3 
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Entry 
Samples 
Polymer 
concentration 
(w/w %)a 
Polymer: 
caffeine 
Fiber 
diameter 
(nm)b 
1 ES_PLA 10 - 2346±718
2 ES_PLA 6 - 2038±723 
3 ES_PLA 4 - 817±172 
4 ES_PLA50 4 1:1 1012±367 
5 ES_PLA20 4 4:1 996±362 
6 ES_PLA10 4 10:1 971±358 
a The PLA concentration in the solvent mixture 
b
 The average fiber diameter and standard deviation was obtained by measuring the size of 200 
individual fibers. 
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Highlights of the submitted manuscript: 
• Raman spectrometry as a potential process analytical technology tool for spray drying 
• Spray dried and electrospun bioresorbable drug delivery systems 
• Electrospun solid solution for smooth release of water soluble drug 
 
 
 
